Day-to-day blood pressure variability predicts poor outcomes following percutaneous coronary intervention: A retrospective study

• Published in: World journal of cardiology 2022-05, Vol.14 (5), p.307-318
• Main Authors: Weisel, Cody L, Dyke, Cornelius M, Klug, Marilyn G, Haldis, Thomas A, Basson, Marc D
• Format: Article
• Language: English
• Subjects: Retrospective Study
• ISSN: 1949-8462; 1949-8462
• DOI: 10.4330/wjc.v14.i5.307

For patients with cardiovascular disease, blood pressure variability (BPV), distinct from hypertension, is an important determinant of adverse cardiac events. Whether pre-operative BPV adversely affects outcomes after percutaneous coronary intervention (PCI) is to this point unclear. To investigate the relationship between blood pressure variability and outcomes for patients post-PCI. Patients undergoing PCI in a single state in 2017 were studied ( = 647). Systolic and diastolic BPV, defined as both the largest change and standard deviation for the 3-60 mo prior to PCI was calculated and patients with more than ten blood pressure measurements in that time were included for analysis ( = 471). Adverse outcomes were identified up to a year following the procedure, including major adverse cardiac events (MACE), myocardial infarction, cerebrovascular accident, death, and all-cause hospitalization. Visit-to-visit systolic BPV, as measured by both standard deviation and largest change, was higher in patients who had myocardial infarction, were readmitted, or died within one year following PCI. Systolic BPV, as measured by largest change or standard deviation, was higher in patients who had MACE, or readmissions ( < 0.05). Diastolic BPV, as measured by largest change, was higher in patients with MACE and readmissions ( < 0.05). As BPV is easily measured and captured in the electronic medical record, these findings describe a novel method of identifying at-risk patients who undergo PCI. Aggressive risk modification for patients with elevated BPV and known coronary artery disease is indicated.